Synapse Medicine: Difference between revisions

From Research Wiki
← Older edit
Added valuation: Series B+; est. ~€50-100M
Added founded year: 2017
 
Line 1: Line 1:
{{Company
{{Company
|name=Synapse Medicine
|name=Synapse Medicine
|founded=2017
|location=Bordeaux, France
|location=Bordeaux, France
|category=Digital Prescription / Medication
|category=Digital Prescription / Medication

Latest revision as of 08:29, 14 April 2026

Template:Company

What They Do[edit]

Digital prescription and medication management platform helping healthcare professionals prescribe safely and manage drug interactions.

Funding[edit]

Valuation: Series B+; est. ~€50-100M Series B+. Backed by BPI France, Elaia Partners.

See Also[edit]

Retrieved from "https://wiki.stamen.health/index.php?title=Synapse_Medicine&oldid=348"